Study Stopped
The research team decided not to implement this study.
A Coach-Guided Online Acceptance and Commitment Therapy (ACT) Intervention for Stroke Survivors
Effects of a Coach-Guided Online Acceptance and Commitment Therapy (ACT) Intervention on Stroke Survivors: A Pilot Randomized Controlled Trial
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The pilot randomized controlled trial aims to assess effects of a guided online acceptance and commitment therapy (ACT) intervention on distressed stroke survivors compared to the care-as-usual control group. A total of 24 stroke survivors who meet the inclusion criteria will be recruited and randomized to either the intervention group or the control group. Exploratory hypotheses are that the ACT group will show improvements in mental health outcomes (e.g., depressive symptoms, anxiety, and stress), and ACT processes (e.g., psychological flexibility/acceptance) at posttest and 2-month follow-up, compared to the care-as-usual control group. Also, the project will evaluate the feasibility of recruitment, adherence, and retention of participants and explore participants' experiences in the ACT intervention through semi-structured interviews at posttest.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2022
Shorter than P25 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 18, 2021
CompletedFirst Posted
Study publicly available on registry
October 27, 2021
CompletedStudy Start
First participant enrolled
January 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 11, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 11, 2022
CompletedMarch 2, 2022
February 1, 2022
1 month
October 18, 2021
February 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change from baseline to immediately after the intervention and 2-month follow-up on the Patient Health Questionnaire-9
The Patient Health Questionnaire-9 is a 9-item questionnaire assessing depressive symptoms on a scale of 0 to 3. Scores range from 0 to 27. Higher scores indicate greater symptomatology in depression.
Change from baseline to immediately after the intervention and 2-month follow-up
Change from baseline to immediately after the intervention and 2-month follow-up on the Generalized Anxiety Disorder-7
The Generalized Anxiety Disorder-7 is a 7-item questionnaire assessing anxiety on a scale of 0 to 3. Scores range from 0 to 21. Higher scores indicate greater anxiety.
Change from baseline to immediately after the intervention and 2-month follow-up
Change from baseline to immediately after the intervention and 2-month follow-up on the Perceived Stress Scale
The Perceived Stress Scale is a 10-item questionnaire assessing stress on a scale of 0 to 4. Scores range from 0 to 40. Higher scores indicate greater stress.
Change from baseline to immediately after the intervention and 2-month follow-up
Secondary Outcomes (7)
Change from baseline to immediately after the intervention and 2-month follow-up on the World Health Organization Quality of Life - Psychological health component
Change from baseline to immediately after the intervention and 2-month follow-up
Change from baseline to immediately after the intervention and 2-month follow-up on the Self-Compassion Scale- Short Form
Change from baseline to immediately after the intervention and 2-month follow-up
Change from baseline to immediately after the intervention and 2-month follow-up on the Patient-Reported Outcomes Measurement Information System (PROMIS) - Meaning and Purpose Short Form
Change from baseline to immediately after the intervention and 2-month follow-up
Change from baseline to immediately after the intervention and 2-month follow-up on the Patient-Reported Outcomes Measurement Information System (PROMIS) Self-Efficacy for Managing Chronic Conditions - Managing Emotions - Short Form
Change from baseline to immediately after the intervention and 2-month follow-up
Change from baseline to immediately after the intervention and 2-month follow-up on the Action and Acceptance Questionnaire-II
Change from baseline to immediately after the intervention and 2-month follow-up
- +2 more secondary outcomes
Other Outcomes (1)
Interviews of participants
Immediately after completing 6 weekly ACT sessions
Study Arms (2)
Acceptance and commitment therapy (ACT) group
EXPERIMENTALA total of 7 ACT sessions individually guided by a trained coach through Zoom videoconferencing
Control group
NO INTERVENTIONCare as usual
Interventions
The intervention group will receive individual ACT sessions guided by a trained coach for one hour per week over 6 weeks through Zoom videoconferencing. Also, a one-time 1-hour booster session will be provided at 1-month follow-up to facilitate the maintenance of treatment effects.
Eligibility Criteria
You may qualify if:
- community-dwelling adults (aged 18 or above) with a confirmed diagnosis of stroke
- having at least mild symptoms of psychological distress measured by the Depression, Anxiety and Stress Scale
- having a computer or a smartphone with internet access at home
- being able to provide informed consent by understanding the nature of study participation
You may not qualify if:
- living in a nursing home at time of consent
- a diagnosis of severe cognitive impairment (e.g., dementia)
- inability to understand spoken and/or written English
- having severe communication difficulties (e.g., aphasia and dysarthria) that can impede study participation
- having a life-threatening illness (e.g. advanced cancer or advanced heart failure) that would make survival for 6 months unlikely
- having a diagnosis of other central nervous system disorders other than stroke or a severe mental illness (e.g., psychosis)
- currently receiving a psychological therapy or participating in another study that may affect mental health
- having a prior experience in ACT
- having psychiatric hospitalizations or diagnoses of mental illness in the previous two years
- taking antipsychotic medication at the time of recruitment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Areum Han, PhD
University of Alabama at Birmingham
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
October 18, 2021
First Posted
October 27, 2021
Study Start
January 9, 2022
Primary Completion
February 11, 2022
Study Completion
February 11, 2022
Last Updated
March 2, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share